China targets fake drugs and bribery in nationwide probe

07/17/2013 | AlertNet

China's State Food and Drug Administration has announced a six-month national campaign aimed at shutting down illegal online drug retailers and stopping sales of fake traditional Chinese medicines. The action comes days after authorities accused GlaxoSmithKline of bribing doctors and health officials to try to boost sales of its drugs by using almost $500 million that was transferred through travel agencies and consultants. China has conducted campaigns in the past to stop false advertising and the sale of counterfeit drugs.

View Full Article in:

AlertNet

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ